Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | BRAF |
Variant | L485_T488delinsF |
Impact List | indel |
Protein Effect | gain of function - predicted |
Gene Variant Descriptions | BRAF L485_T488delinsF results in a deletion of four amino acids in the protein kinase domain of the Braf protein from amino acids 485 to 488, combined with the insertion of a phenylalanine (F) at the same site (UniProt.org). L485_T488delinsF has not been characterized, however, is predicted to lead to a gain of protein function due to other characterized BRAF deletions in the same region (PMID: 37656784). |
Associated Drug Resistance | |
Category Variants Paths |
BRAF mutant BRAF act mut BRAF L485_T488delinsF |
Transcript | NM_004333.6 |
gDNA | chr7:g.140778044_140778055delinsAAA |
cDNA | c.1453_1464delinsTTT |
Protein | p.L485_T488delinsF |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001378474.1 | chr7:g.140778044_140778055delinsAAA | c.1453_1464delinsTTT | p.L485_T488delinsF | RefSeq | GRCh38/hg38 |
NM_004333.6 | chr7:g.140778044_140778055delinsAAA | c.1453_1464delinsTTT | p.L485_T488delinsF | RefSeq | GRCh38/hg38 |
NM_001378468.1 | chr7:g.140778044_140778055delinsAAA | c.1453_1464delinsTTT | p.L485_T488delinsF | RefSeq | GRCh38/hg38 |
NM_001354609.2 | chr7:g.140778044_140778055delinsAAA | c.1453_1464delinsTTT | p.L485_T488delinsF | RefSeq | GRCh38/hg38 |
XM_047420769.1 | chr7:g.140778044_140778055delinsAAA | c.1453_1464delinsTTT | p.L485_T488delinsF | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
BRAF L485_T488delinsF | Advanced Solid Tumor | predicted - resistant | Dabrafenib | Preclinical - Biochemical | Actionable | In a preclinical study, cells expressing BRAF L485_T488delinsF were resistant to Tafinlar (dabrafenib)-induced inhibition of ERK and MEK signaling in culture (PMID: 37656784). | 37656784 |
BRAF L485_T488delinsF | Advanced Solid Tumor | predicted - sensitive | Sorafenib | Preclinical - Biochemical | Actionable | In a preclinical study, Nexavar (sorafenib) inhibited ERK and MEK signaling in cells expressing BRAF L485_T488delinsF in culture (PMID: 37656784). | 37656784 |
BRAF L485_T488delinsF | Advanced Solid Tumor | predicted - sensitive | LXH 254 | Preclinical - Biochemical | Actionable | In a preclinical study, LXH 254 inhibited ERK and MEK signaling in cells expressing BRAF L485_T488delinsF in culture (PMID: 37656784). | 37656784 |